1 |
Fitzgerald DW, Sterling TR. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. New York, NY: Churchill-Livingstone 2010:3129-64.
|
2 |
Scott C, Kirking HL, Jeffries C, et al. Tuberculosis trends--United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64:265-9
|
3 |
McDonald E, Smith-Palmer A, Wallace LA, et al. Risk factors for TB and HIV coinfection in Scotland, 2001 to 2010. Euro Surveill 2015;20. pii: 21067.
|
4 |
Sun HY, Hsueh PR, Liu WC, et al. Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test. PLoS One 2015;10:e0125260.
DOI
|
5 |
Sasaki S, Sullivan M, Narvaez CF, et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011;121:3109-19.
DOI
|
6 |
Gavazzi G, Herrmann F, Krause KH. Aging and infectious diseases in the developing world. Clin Infect Dis 2004;39:83-91.
DOI
|
7 |
Cruz-Hervert LP, Garcia-Garcia L, Ferreyra-Reyes L, et al. Tuberculosis in ageing: high rates, complex diagnosis and poor clinical outcomes. Age Ageing 2012;41:488-95.
DOI
|
8 |
World Health Organization. Global Tuberculosis Report, 2017. Available from http://apps.who.int/iris/bitstream/10665/259366/1/9789241565516-eng.pdf?ua=1. Accessed March 08, 2018.
|
9 |
Korean Statistical Information Service. TB prevalence by sex and age. Available from http://kosis.kr/statisticsList/statisticsListIndex.do?menuId=M_01_01&vwcd=MT_ZTITLE&parmTabId=M_01_01#SelectStats-BoxDiv. Accessed January 05, 2018.
|
10 |
Joint Committee for the Revision of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. Korean Guidelines for Tuberculosis, Third Edition, 2017.
|
11 |
Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016;63:e147-95.
DOI
|
12 |
Franke F, Appleton C, Arteaga F, et al. Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis 2008;46:1844-51.
DOI
|
13 |
Chino H, Hagiwara E, Sekine A, et al. Compliance rate of standard treatment regimen and optimal dose of anti-tuberculosis drugs in late elderly patients with pulmonary tuberculosis. Kekkaku 2016;91;495-502.
|
14 |
Velayutham BR, Nair D, Chandrasekaran V, et al. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India. PLoS One 2014;9:e88045.
DOI
|
15 |
Oshi DC, Oshi SN, Alobu I, et al. Profile and treatment outcomes of tuberculosis in the elderly in southeastern Nigeria, 2011-2012. PLoS One 2014;9:e111910.
DOI
|
16 |
Dheda K, Barry CE, Maartens G. Tuberculosis. Lancet. 2016; 387:1211-26.
DOI
|
17 |
Rhines AS. The role of sex differences in the prevalence and transmission of tuberculosis. Tuberculosis (Edinb) 2013;93:104-7.
DOI
|
18 |
Khan MS, Khan MS, Hasan R, et al. Unusual sex differences in tuberculosis notifications across Pakistan and the role of environmental factors. East Mediterr Health J 2013;19:821-5.
DOI
|